4.3 Review

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting

期刊

CTS-CLINICAL AND TRANSLATIONAL SCIENCE
卷 10, 期 3, 页码 143-146

出版社

WILEY
DOI: 10.1111/cts.12456

关键词

-

资金

  1. National Institutes of Health (NIH) [U01 HG007269, U01 HG007775, U01 HG007253, U01 HG007762]
  2. NIH IGNITE network
  3. NIH [U01 GM074492, U01 HL105198, K23 GM112014, UL1TR0000005, R01HL092173, 1K24HL133373, UL1TR000165, R01 GM088076]
  4. University of Florida and its Clinical Translational Science Institute [UL1 TR000064, UL1 TR001427]
  5. University of Maryland Medical Center and University of Maryland School of Medicine Program for Personalized and Genomic Medicine
  6. University of Illinois at Chicago Offices of the Vice President for Health Affairs and Vice Chancellor
  7. American Society of Health System Pharmacists
  8. Anonymous Donor for PEE
  9. Penn Center for Precision Medicine at the Perelman School of Medicine at the University of Pennsylvania
  10. University of Alabama, Birmingham Health Service Foundations' General Endowment Fund
  11. Indiana University Health - Indiana University School of Medicine Strategic Research Initiative

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据